Uptrend Call Working As Amedisys Stock Rises 56.1% (AMED)
Comtex SmarTrend(R) - Tue Nov 11, 10:58AM CST
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 5 months, Amedisys has returned 56.08% as of today's recent price of $24.98.
AMED: 25.09 (-0.02)
Earnings Look Back: Amedisys Is Down 1.7% Since Reporting Quarterly Results 1 Week Ago (AMED)
Comtex SmarTrend(R) - Mon Nov 10, 11:50AM CST
A week ago on October 29th, 2014 Amedisys (NASDAQ:AMED) reported earnings and analysts, on average, expected earnings of $0.15 on sales of $299.2 million. The company actually reported EPS of $0.28 on sales of $300.3 million, beating EPS estimates by $0.13 and beating revenue estimates by $1.1 million. Shares of Amedisys have slipped from $25.22 to $24.79, representing a loss of 1.7%, since the company reported earnings 12 days ago.
AMED: 25.09 (-0.02)
Amsurg's Q3 Earnings Top on Revenue Growth, View Raised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 11:20AM CST
Amsurg Corp. (AMSG) reported third-quarter 2014 adjusted earnings per share (EPS) of 66 cents from continuing operations.
CHE: 107.88 (-2.12), AMSG: 50.26 (-0.16), RDNT: 8.30 (-0.05), AMED: 25.09 (-0.02)
2014 HomeCare Elite Recognizes Top Amedisys Care Teams Nationwide
GlobeNewswire - Wed Nov 05, 10:00AM CST
Amedisys, a leading healthcare at home company (Nasdaq:AMED), today announced that 162 of its care centers across the country have been named to the 2014 HomeCare Elite(TM), a compilation of the top-performing home health agencies in the United States compiled annually by OCS Home Care and DecisionHealth.
NRCIA: 17.97 (+0.02), AMED: 25.09 (-0.02), NRCIB: 34.14 (-0.10)
Can Amedisys (AMED) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 7:50AM CST
Amedisys could be an interesting play for investors as the stock has a decent short-term momentum and is seeing solid activity on the earnings estimate revision
AMED: 25.09 (-0.02)
Amedisys Up 61.4% Since SmarTrend Uptrend Call (AMED)
Comtex SmarTrend(R) - Tue Nov 04, 9:40AM CST
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 4 months, Amedisys has returned 61.39% as of today's recent price of $25.83.
AMED: 25.09 (-0.02)
Your Best Stocks Will Be in the Best Industries - Screen of the Week
Kevin Matras - Zacks Investment Research - Tue Nov 04, 3:01AM CST
Your Best Stocks Will Be in the Best Industries - Screen of the Week
BCC: 37.19 (-0.01), HNI: 46.78 (-1.17), ALDW: 17.59 (-1.28), AMED: 25.09 (-0.02), FLWS: 9.01 (-0.02)
Is Emerson Electric (EMR) Likely to Miss on Earnings Again? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 2:51PM CDT
Emerson Electric Co. (EMR), a global technological solutions provider, is set to report fourth-quarter and full-year 2014 results on Nov 4, before the opening bell.
BBRY: 12.06 (+0.79), EMR: 63.52 (-0.53), AMED: 25.09 (-0.02), AAPL: 112.82 (+1.57)
Amedysis Turns Around with Q3 Earnings Beat, Shares Rally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 1:50PM CDT
Following Amedisys' (AMED) promising earnings announcement, the company's stock price surged 16.2% to eventually close at $25.28 yesterday.
AMSG: 50.26 (-0.16), USPH: 39.36 (-0.34), RDNT: 8.30 (-0.05), AMED: 25.09 (-0.02)
Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
ACPW: 1.87 (unch), ACMP: 61.72 (-0.02), AMAG: 34.24 (-0.69), AMED: 25.09 (-0.02), ACCO: 8.80 (-0.06)
Amedisys (AMED) Upgraded From Hold to Buy
at The Street - Fri Oct 31, 8:09AM CDT
Amedisys (AMED) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
AMED: 25.09 (-0.02)
Nasdaq stocks posting largest percentage increases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
IMDZ: 35.97 (+5.30), ABMD: 33.48 (-0.12), BGFV: 13.32 (-0.06), RDCM: 9.34 (+0.04), AMED: 25.09 (-0.02), MRCY: 13.41 (-0.22), OMER: 19.57 (-0.14), ESBF: 18.78 (-0.49), EVOK: 6.40 (+0.10), IQNT: 18.51 (-0.11), KONA: 22.85 (-0.16), TQNT: 22.17 (+0.07), LAKE: 11.39 (-0.85), SAJA: 6.21 (+0.31)
Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 50.75 (+0.24), ZLTQ: 26.77 (-0.63), EA: 41.44 (+0.24), AMED: 25.09 (-0.02)
Critical Alerts For General Electric, Amedisys Inc, RF Micro Devices, JC Penney and SolarCity Released By InvestorsObserver
PR Newswire - Thu Oct 30, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GE, AMED, RFMD, JCP and SCTY.
GE: 26.42 (-0.10), SCTY: 50.84 (-1.21), JCP: 7.10 (-0.66), AMED: 25.09 (-0.02), RFMD: 13.33 (+0.08)
Amedisys Inc. (AMED) in Focus: Stock Surges 15.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:21AM CDT
Amedisys Inc. (AMED) was a big mover last session, as the company saw its shares rise nearly 16% on the day.
AMSG: 50.26 (-0.16), USPH: 39.36 (-0.34), RDNT: 8.30 (-0.05), AMED: 25.09 (-0.02)
Upgrade Alert for Amedisys (AMED)
Comtex SmarTrend(R) - Thu Oct 30, 6:53AM CDT
Amedisys (NASDAQ:AMED) was upgraded from Underperform to Neutral at RW Baird today. The stock closed yesterday at $25.22 on volume of 1.6 million shares, above average daily volume of 269,000. Amedisys (NASDAQ:AMED) is currently priced 31.4% above its average consensus analyst price target of $17.31. The stock should find initial support at its 50-day moving average (MA) of $20.78 and further support at its 200-day MA of $16.87.
AMED: 25.09 (-0.02)
Amedisys' (AMED) CEO Ronald LaBorde on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 12:50PM CDT
AMED: 25.09 (-0.02)
Amedisys ups earnings 109% in Q3
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 12:23PM CDT
AMED: 25.09 (-0.02)